Хайлтын үр дүнгүүд - Takashi Semba
- 11-н 1 - 11 үр дүнгүүдийг харуулж байна
-
1
-
2
-
3
-
4
Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. -н Yuji Yamanashi, Masato Okada, Takashi Semba, Takao Yamori, Hisashi Umemori, Susumu Tsunasawa, K Toyoshima, Daisuke Kitamura, Tomohiro Watanabe, Tohru Yamamoto
Хэвлэсэн 1993Artigo -
5
Synthetic lethality of the ALDH3A1 inhibitor dyclonine and xCT inhibitors in glutathione deficiency-resistant cancer cells -н Shogo Okazaki, Subaru Shintani, Yuki Hirata, Kentaro Suina, Takashi Semba, Juntaro Yamasaki, Kiyoko Umene, Miyuki Ishikawa, Hideyuki Saya, Osamu Nagano
Хэвлэсэн 2018Artigo -
6
TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung Adenocarcinoma -н Ryo Sato, Kosuke Imamura, Takashi Semba, Yusuke Tomita, Sho Saeki, Koei Ikeda, Yoshihiro Komohara, Makoto Suzuki, Takuro Sakagami, Hideyuki Saya, Yoshimi Arima
Хэвлэсэн 2021Artigo -
7
Cellular senescence induction leads to progressive cell death via the INK4a‐RB pathway in naked mole‐rats -н Yoshimi Kawamura, Kaori Oka, Takashi Semba, Mayuko Takamori, Yuki Sugiura, Riyo Yamasaki, Yusuke Suzuki, Takeshi Chujo, M Nagase, Yuki Oiwa, Shusuke Fujioka, Sayuri Homma, Yuki Yamamura, Shingo Miyawaki, Minoru Narita, Takaichi Fukuda, Yusuke Sakai, Takatsugu Ishimoto, Kazuhito Tomizawa, Makoto Suematsu, Takuya Yamamoto, Hidemasa Bono, Hideyuki Okano, Kyoko Miura
Хэвлэсэн 2023Artigo -
8
Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors -н Takahiko Akiyama, Tadahito Yasuda, Tomoyuki Uchihara, Noriko Yasuda‐Yoshihara, Benjy J.Y. Tan, Atsuko Yonemura, Takashi Semba, Juntaro Yamasaki, Yoshihiro Komohara, Koji Ohnishi, Wei Feng, Lingfeng Fu, Jun Zhang, Fumimasa Kitamura, Kohei Yamashita, Kojiro Eto, Shiro Iwagami, Hirotake Tsukamoto, Terumasa Umemoto, Mari Masuda, Osamu Nagano, Yorifumi Satou, Hideyuki Saya, Patrick Tan, Hideo Baba, Takatsugu Ishimoto
Хэвлэсэн 2022Artigo -
9
Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer -н Fumimasa Kitamura, Takashi Semba, Noriko Yasuda‐Yoshihara, Kosuke Yamada, Akiho Nishimura, Juntaro Yamasaki, Osamu Nagano, Tadahito Yasuda, Atsuko Yonemura, Yilin Tong, Huaitao Wang, Takahiko Akiyama, Kazuki Matsumura, Norio Uemura, Rumi Itoyama, Luke Bu, Lingfeng Fu, Xichen Hu, Feng Wei, Kosuke Mima, Katsunori Imai, Hiromitsu Hayashi, Yo‐ichi Yamashita, Yuji Miyamoto, Hideo Baba, Takatsugu Ishimoto
Хэвлэсэн 2023Artigo -
10
EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer -н Xiaoping Wang, Takashi Semba, Ganiraju C. Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Phi, Troy Pearson, Steven Van Laere, Jared K. Burks, Evan N. Cohen, James M. Reuben, Fei Yang, Min Hu, Nicholas E. Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Vardhan Batra, Yichao Shen, Xiang H.-F. Zhang, Debu Tripathy, Naoto T. Ueno
Хэвлэсэн 2022Artigo -
11
Mesothelial cells with mesenchymal features enhance peritoneal dissemination by forming a protumorigenic microenvironment -н Atsuko Yonemura, Takashi Semba, Jun Zhang, Yibo Fan, Noriko Yasuda‐Yoshihara, Huaitao Wang, Tomoyuki Uchihara, Tadahito Yasuda, Akiho Nishimura, Lingfeng Fu, Xichen Hu, Feng Wei, Fumimasa Kitamura, Takahiko Akiyama, Kohei Yamashita, Kojiro Eto, Shiro Iwagami, Masaaki Iwatsuki, Yuji Miyamoto, Keisuke Matsusaki, Juntaro Yamasaki, Osamu Nagano, Hideyuki Saya, Shumei Song, Patrick Tan, Hideo Baba, Jaffer A. Ajani, Takatsugu Ishimoto
Хэвлэсэн 2024Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Cancer research
Biology
Cancer
Cell biology
Medicine
Internal medicine
Biochemistry
Tumor microenvironment
Cancer cell
Chemistry
Gene
Immunology
Molecular biology
Receptor
Chemokine
Enzyme
Genetics
Immune system
Immunotherapy
Mesenchymal stem cell
Pathology
Signal transduction
Stem cell
Adenocarcinoma
Antibody
Apoptosis
Blockade
Breast cancer
CCL2
Cancer immunotherapy